Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G.

Cell Metab. 2006 Dec;4(6):441-51.

2.

Protein nutrition as therapy for a genetic disorder of bone?

Martin TJ.

Cell Metab. 2006 Dec;4(6):419-20.

3.

ATF4 is a key molecule linking food intake and skeletal development.

Sowa H, Karsenty G.

J Musculoskelet Neuronal Interact. 2007 Oct-Dec;7(4):326-7. No abstract available.

4.

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.

Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G.

Cell. 2004 Apr 30;117(3):387-98.

5.

Leptin regulation of bone resorption by the sympathetic nervous system and CART.

Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G.

Nature. 2005 Mar 24;434(7032):514-20. Epub 2005 Feb 20.

PMID:
15724149
6.

Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression.

Mak KK, Bi Y, Wan C, Chuang PT, Clemens T, Young M, Yang Y.

Dev Cell. 2008 May;14(5):674-88. doi: 10.1016/j.devcel.2008.02.003.

7.

Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

David JP, Mehic D, Bakiri L, Schilling AF, Mandic V, Priemel M, Idarraga MH, Reschke MO, Hoffmann O, Amling M, Wagner EF.

J Clin Invest. 2005 Mar;115(3):664-72.

8.

c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.

He Y, Rhodes SD, Chen S, Wu X, Yuan J, Yang X, Jiang L, Li X, Takahashi N, Xu M, Mohammad KS, Guise TA, Yang FC.

PLoS One. 2012;7(11):e46900. doi: 10.1371/journal.pone.0046900. Epub 2012 Nov 7.

9.

Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.

Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F.

Hum Mol Genet. 2011 Oct 15;20(20):3910-24. doi: 10.1093/hmg/ddr310. Epub 2011 Jul 14.

10.

RSK2 protects mice against TNF-induced bone loss.

Böhm C, Derer A, Axmann R, Hillienhoff U, Zaiss MM, Luther J, Zech C, Stock M, Scholtysek C, Engelke K, Hess A, Tuckermann JP, Schett G, David JP.

J Cell Sci. 2012 May 1;125(Pt 9):2160-71. doi: 10.1242/jcs.096008. Epub 2012 Feb 17.

11.

Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.

Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, Yan J, Morgan T, Li X, Yuan J, Hock J, Ingram DA, Clapp DW.

J Clin Invest. 2006 Nov;116(11):2880-91. Epub 2006 Oct 19.

13.

Regulation of bone formation and remodeling by G-protein-coupled receptor 48.

Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z, Cho SG, Li C, Yi T, Wu X, Li XY, de Crombrugghe B, Höök M, Liu M.

Development. 2009 Aug;136(16):2747-56. doi: 10.1242/dev.033571. Epub 2009 Jul 15.

14.

The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid.

Ammar MR, Humeau Y, Hanauer A, Nieswandt B, Bader MF, Vitale N.

J Neurosci. 2013 Dec 11;33(50):19470-9. doi: 10.1523/JNEUROSCI.2283-13.2013.

15.

Cbfβ deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfβ required for skeletal development.

Chen W, Ma J, Zhu G, Jules J, Wu M, McConnell M, Tian F, Paulson C, Zhou X, Wang L, Li YP.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8482-7. doi: 10.1073/pnas.1310617111. Epub 2014 May 21.

16.

FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.

Yu VW, Ambartsoumian G, Verlinden L, Moir JM, Prud'homme J, Gauthier C, Roughley PJ, St-Arnaud R.

J Cell Biol. 2005 May 23;169(4):591-601.

17.

Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior.

Poirier R, Jacquot S, Vaillend C, Soutthiphong AA, Libbey M, Davis S, Laroche S, Hanauer A, Welzl H, Lipp HP, Wolfer DP.

Behav Genet. 2007 Jan;37(1):31-50. Epub 2006 Oct 11.

PMID:
17033934
18.

Chondrocytic Atf4 regulates osteoblast differentiation and function via Ihh.

Wang W, Lian N, Ma Y, Li L, Gallant RC, Elefteriou F, Yang X.

Development. 2012 Feb;139(3):601-11. doi: 10.1242/dev.069575. Epub 2011 Dec 21.

19.

Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.

Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, Mayahara M, Suzuki K, Imai T, Ito M, Manome Y, Yasuhara M, Kirino T, Yamaguchi A, Matsushima K, Yamamoto K.

J Biol Chem. 2010 Sep 10;285(37):28826-37. doi: 10.1074/jbc.M109.099424. Epub 2010 Jun 22.

20.

Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.

Lian N, Lin T, Liu W, Wang W, Li L, Sun S, Nyman JS, Yang X.

J Biol Chem. 2012 Oct 19;287(43):35975-84. doi: 10.1074/jbc.M112.372458. Epub 2012 Sep 4.

Supplemental Content

Support Center